CM Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.65M	Buy	2,250,000 +102,500	+5%	+$75K	1.5%	25
2025 Q1	$1.73M	Buy	2,147,500 +97,500	+5%	+$78.7K	1.74%	26
2024 Q4	$2.83M	Buy	2,050,000 +50,000	+3%	+$69K	2.53%	13
2024 Q3	$2.08M	Buy	2,000,000 +900,000	+82%	+$936K	1.66%	28
2024 Q2	$1.9M	Buy	1,100,000 +100,000	+10%	+$173K	1.75%	23
2024 Q1	$2.39M	Buy	1,000,000 +176,000	+21%	+$421K	2.01%	18
2023 Q4	$2.74M	Buy	824,000 +276,000	+50%	+$919K	2.21%	13
2023 Q3	$2.05M	Buy	548,000 +98,000	+22%	+$367K	2.17%	15
2023 Q2	$1.92M	Buy	450,000 +250,000	+125%	+$1.07M	1.87%	18
2023 Q1	$1.37M	Buy	200,000 +25,000	+14%	+$171K	1.62%	20
2022 Q4	$1.39M	Sell	175,000 -25,000	-13%	-$198K	1.66%	17
2022 Q3	$1.92M	Hold	200,000	–	–	2.15%	16
2022 Q2	$1.45M	Buy	200,000 +50,000	+33%	+$362K	1.54%	25
2022 Q1	$1.94M	Buy	150,000 +25,000	+20%	+$323K	1.63%	23
2021 Q4	$2M	Hold	125,000	–	–	1.51%	19
2021 Q3	$2.01M	Buy	125,000 +25,000	+25%	+$402K	1.5%	17
2021 Q2	$1.38M	Buy	100,000 +25,000	+33%	+$346K	1%	34
2021 Q1	$1.1M	Buy	75,000 +15,000	+25%	+$219K	0.81%	49
2020 Q4	$1.04M	Buy	+60,000	New	+$1.04M	0.97%	33